市場調査レポート

商品コード

1781176

外側上顆炎治療の世界市場、治療タイプ別、年齢層別、エンドユーザー別、地域別、機会、予測、2018年～2032年

Global Lateral Epicondylitis Treatment Market Assessment, By Treatment Type, By Age Group, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日: 2025年08月01日
発行: Markets & Data
ページ情報: 英文 235 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,800 717,408円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 6,000 896,760円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,500 1,270,410円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.46円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の外側上顆炎治療市場は、予測期間2025-2032年にCAGR 6.05％を記録し、2024年の14億7,000万米ドルから2032年には23億5,000万米ドルに成長すると予測されています。肘関節の痛みの増加とともに、肘腱腫脹の有病率の上昇が世界市場を牽引する主な要因です。肘や腕の反復運動がテニス肘（外側上顆炎）の主な原因です。

世界の外側上顆炎治療市場は、反復性疲労傷害の増加やスポーツ参加者の増加、筋骨格系の問題に直面する労働人口の高齢化などにより、一貫した成長を遂げています。外側上顆炎（テニス肘）は、前腕の筋肉の繰り返しが原因で肘の外側に炎症とともに痛みを引き起こす病状です。この市場には、外科的処置と非外科的選択肢を含む様々な治療法があるが、患者が非外科的アプローチを選択するのは、理学療法やNSAIDsのほか、副腎皮質ステロイド注射、PRP、装具装具、さらに衝撃波療法などです。この市場は、装着型肘装具や体外衝撃波治療（ESWT）装置などの再生医療を含む技術開発のおかげで成長を遂げています。世界市場が北米で主導的地位を占めているのは、先進的なヘルスケアシステムと人々の意識の高まりによるものであるが、アジア太平洋地域は理学療法と外来治療の利用可能性が高まっているため、最も速い市場成長を示しています。将来の市場機会は、早期診断イニシアチブの増加、理学療法保険適用の改善、PRPと生物製剤の臨床研究から生まれると思われます。競合環境は、回復期間を短縮しながら患者の結果を改善する製品を開発し、世界市場に事業を開拓する製薬会社、医療機器メーカー、治療サービスプロバイダーで構成されます。

例えば、コルプラントは2025年2月、同社のVergenix STR製品の販売チャネルを欧州とアジアに拡大したと発表しました。Vergenix STRは当社のrhCollagenテクノロジーに基づき、肘腱（テニス肘治療用）、回旋筋腱板、膝蓋腱、アキレス腱、手指腱など様々な腱の損傷の治癒と修復を促進する腱障害治療に使用されます。

市場規模分析と予測
- 金額別
市場シェア分析と予測
- 治療タイプ別
  - 非外科的治療
  - 外科的治療
- 年齢層別
  - 小児
  - 成人
  - 高齢者
- エンドユーザー別
  - 病院
  - 外来手術センター
  - 整形外科クリニック
  - 在宅ケア設定
  - その他
- 地域別
  - 北米
  - 欧州
  - アジア太平洋
  - 南米
  - 中東およびアフリカ
- 企業別市場シェア分析（上位5社およびその他- 金額別、2024年）
2024年市場マップ分析
- 治療タイプ別
- 年齢層別
- エンドユーザー別
- 地域別

第6章北米の外側上顆炎治療市場の展望、2018年～2032年

市場規模分析と予測
- 金額別
市場シェア分析と予測
- 治療タイプ別
  - 非外科的治療
  - 外科的治療
- 年齢層別
  - 小児
  - 成人
  - 高齢者
- エンドユーザー別
  - 病院
  - 外来手術センター
  - 整形外科クリニック
  - 在宅ケア設定
  - その他
- 国別シェア
  - 米国
  - カナダ
  - メキシコ
国別市場評価
- 米国の外側上顆炎治療市場の展望、2018年～2032年予測
  - 市場規模分析と予測
  - 市場シェア分析と予測
- カナダ
- メキシコ

すべてのセグメントは、対象となるすべての地域と国に提供されます。

第7章欧州の外側上顆炎治療市場の展望、2018年～2032年

ドイツ
フランス
イタリア
英国
ロシア
オランダ
スペイン
トルコ
ポーランド

第8章アジア太平洋地域の外側上顆炎治療市場の展望、2018年～2032年

インド
中国
日本
オーストラリア
ベトナム
韓国
インドネシア
フィリピン

第9章南米の外側上顆炎治療市場の展望、2018年～2032年

ブラジル
アルゼンチン

第10章中東・アフリカの外側上顆炎治療市場の展望、2018年～2032年

サウジアラビア
アラブ首長国連邦
南アフリカ

第11章ポーターのファイブフォース分析

第12章 PESTLE分析

第13章価格分析

第14章市場力学

市場促進要因
市場の課題

第15章市場動向と発展

第16章規制枠組みとイノベーション

規制当局の承認
臨床試験

第17章特許の情勢

第18章ケーススタディ

第19章競合情勢

市場リーダー上位5社の競合マトリックス
トップ5企業のSWOT分析
市場トップ10の主要企業の情勢
- Pfizer, Inc.
- GlaxoSmithKline plc
- 3M Company
- Merck &Co., Inc.
- Bayer AG
- Cipla Inc.
- Novartis AG
- Embla Medical hf.
- Zimmer Biomet Holdings, Inc.
- Enovis Corporation（DJO, LLC）

上記の企業は市場シェアに応じて注文を保留するものではなく、調査作業中に入手可能な情報に応じて変更される可能性があります。

第20章戦略的提言

第21章調査会社について・免責事項

図表

List of Tables

Table 1. Competition Matrix of Top 5 Market Leaders
Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 2. Global Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 3. Global Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 4. Global Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 5. Global Lateral Epicondylitis Treatment Market Share (%), By Region, 2018-2032F
Figure 6. North America Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 7. North America Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 8. North America Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 9. North America Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 10. North America Lateral Epicondylitis Treatment Market Share (%), By Country, 2018-2032F
Figure 11. United States Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 12. United States Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 13. United States Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 14. United States Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 15. Canada Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 16. Canada Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 17. Canada Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 18. Canada Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 19. Mexico Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 20. Mexico Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 21. Mexico Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 22. Mexico Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 23. Europe Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 24. Europe Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 25. Europe Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 26. Europe Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 27. Europe Lateral Epicondylitis Treatment Market Share (%), By Country, 2018-2032F
Figure 28. Germany Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 29. Germany Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 30. Germany Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 31. Germany Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 32. France Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 33. France Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 34. France Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 35. France Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 36. Italy Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 37. Italy Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 38. Italy Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 39. Italy Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 40. United Kingdom Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 41. United Kingdom Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 42. United Kingdom Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 43. United Kingdom Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 44. Russia Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 45. Russia Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 46. Russia Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 47. Russia Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 48. Netherlands Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 49. Netherlands Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 50. Netherlands Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 51. Netherlands Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 52. Spain Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 53. Spain Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 54. Spain Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 55. Spain Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 56. Turkey Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 57. Turkey Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 58. Turkey Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 59. Turkey Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 60. Poland Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 61. Poland Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 62. Poland Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 63. Poland Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 64. South America Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 65. South America Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 66. South America Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 67. South America Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 68. South America Lateral Epicondylitis Treatment Market Share (%), By Country, 2018-2032F
Figure 69. Brazil Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 70. Brazil Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 71. Brazil Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 72. Brazil Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 73. Argentina Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 74. Argentina Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 75. Argentina Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 76. Argentina Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 77. Asia-Pacific Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 78. Asia-Pacific Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 79. Asia-Pacific Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 80. Asia-Pacific Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 81. Asia-Pacific Lateral Epicondylitis Treatment Market Share (%), By Country, 2018-2032F
Figure 82. India Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 83. India Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 84. India Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 85. India Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 86. China Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 87. China Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 88. China Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 89. China Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 90. Japan Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 91. Japan Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 92. Japan Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 93. Japan Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 94. Australia Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 95. Australia Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 96. Australia Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 97. Australia Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 98. Vietnam Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 99. Vietnam Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 100. Vietnam Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 101. Vietnam Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 102. South Korea Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 103. South Korea Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 104. South Korea Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 105. South Korea Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 106. Indonesia Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 107. Indonesia Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 108. Indonesia Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 109. Indonesia Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 110. Philippines Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 111. Philippines Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 112. Philippines Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 113. Philippines Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 114. Middle East & Africa Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 115. Middle East & Africa Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 116. Middle East & Africa Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 117. Middle East & Africa Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 118. Middle East & Africa Lateral Epicondylitis Treatment Market Share (%), By Country, 2018-2032F
Figure 119. Saudi Arabia Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 120. Saudi Arabia Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 121. Saudi Arabia Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 122. Saudi Arabia Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 123. UAE Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 124. UAE Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 125. UAE Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 126. UAE Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 127. South Africa Lateral Epicondylitis Treatment Market, By Value, In USD Billion, 2018-2032F
Figure 128. South Africa Lateral Epicondylitis Treatment Market Share (%), By Treatment Type, 2018-2032F
Figure 129. South Africa Lateral Epicondylitis Treatment Market Share (%), By Age Group, 2018-2032F
Figure 130. South Africa Lateral Epicondylitis Treatment Market Share (%), By End-user, 2018-2032F
Figure 131. By Treatment Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 132. By Age Group Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024

Product Code: MX13834

Global lateral epicondylitis treatment market is projected to witness a CAGR of 6.05% during the forecast period 2025-2032, growing from USD 1.47 billion in 2024 to USD 2.35 billion in 2032. Rising prevalence of elbow tendons swelling, coupled with increasing incidences of pain in elbow joints, are the major factors driving the global market. The repetitive motion of the elbow and arms is the main reason for tennis elbow (lateral epicondylitis).

Global lateral epicondylitis treatment market experiences consistent growth because of increasing repetitive strain injury numbers and growing sports participation, and an aging workforce facing musculoskeletal problems. Lateral epicondylitis, or tennis elbow, is a medical condition that causes pain together with inflammation at the outer elbow due to repeated forearm muscles. The market contains various treatment methods, which include surgical procedures and non-surgical options, but patients choose non-surgical approaches, including physiotherapy and NSAIDs, as well as corticosteroid injections, PRP and orthotic bracing, together with shockwave therapy, because these treatments are less invasive and more people are choosing them. The market experiences growth thanks to technological developments, which include regenerative medicine along with wearable elbow braces and extracorporeal shockwave therapy (ESWT) devices. The global market finds its leading position in North America because of advanced healthcare systems and elevated public awareness, yet the Asia-Pacific region shows the fastest market growth because of rising physiotherapy and outpatient care availability. The future market opportunities will emerge from increased early diagnosis initiatives and better physical therapy insurance coverage, and PRP and biologics clinical research. The competitive environment consists of pharmaceutical companies, medical device manufacturers and therapy services providers who develop products to improve patient results while shortening recovery periods and expanding their business into global markets.

For instance, in February 2025, CollPlant announced that it expanded the distribution channels for its Vergenix STR product in Europe and Asia. Vergenix STR is based on the Company's rhCollagen technology and is used for the treatment of tendinopathy that promotes healing and repair of tendon injuries to various tendons, including elbow tendons (for treating tennis elbow), rotator cuffs, patellar tendons, achilles tendons, and hand tendons.

Rising Cases of Bone Injuries Boost Market Demand

The rising cases of bone-related injuries are a major factor driving growth in the lateral epicondylitis treatment market. As more individuals participate in physically demanding activities such as sports, fitness, and manual labor, the incidence of injuries to bones (fractures, stress injuries, and damage to the joints) has steadily increased. Bone injuries can lead to compensation by surrounding muscles and tendons, resulting in lateral epicondylitis. Second, individuals recovering from bone injuries often develop secondary complications due to improper movement or stressing and straining unaffected limbs. This increased demand for orthopedic care, physiotherapy, and rehabilitation creates a demand for recovery of significant magnitude (braces, shockwave treatment, and/or non-invasive pain management). Thus, the demand for improved recovery options has led to better treatment options. Healthcare providers have also included the ability to demand comprehensive musculoskeletal care, which creates demand for growth opportunities for the lateral epicondylitis treatment market.

For instance, in January 2025, Journavx (suzetrigine), an oral tablet formulation of 50 mg, became the first non-opioid analgesic to be approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe acute pain in adults. Journavx is the first drug in the new class of approved pain management agents. Such a tablet immediately acts and reduces pain.

Increase in the Number of Sport Activities Support Market Expansion

The growing sports participation across the world is increasing demand for the lateral epicondylitis treatment market. As we emphasize health, fitness, and recreation more, participation in sports is increasing, including sports such as tennis, badminton, golf, and weight training, all of which can involve repeated arm movement, placing strain on the forearm tendons. An increase in physical activity and sport participation will increase overuse injuries such as lateral epicondylitis, also known as tennis elbow. Both amateur and professional athletes want effective, non-invasive solutions for lateral epicondylitis that work and have a minimal recovery time, allowing athletes to get back in action very quickly. More and more demand from athletes to return to sport means there's more of a demand for physiotherapy, orthopedic bracing, platelet-rich plasma (PRP) injections, and shockwave therapy. Sports clinics, fitness facilities, and physiotherapy providers are expanding services to meet demand and interest. The idea of an active and fit lifestyle for sport participation/or exercise is a growing trend. The increase in sport participation for clinicians and researchers of all ages helps to grow the market and especially for lateral epicondylitis treatment.

For instance, according to the newly published Sports & Fitness Industry Association (SFIA) Topline Participation Report in 2023 highlights that 242 million Americans, or 78.8% of Americans, have participated in an activity once or more (up 2.2% from last year). Participation has increased year after year (10 straight years), increasing an additional 5 million participants in activities in 2023.

Non-Surgical Treatment Holds the Largest Market Share

Non-surgical treatment holds the largest share of the lateral epicondylitis treatment market segment because of its convenient access, together with better safety and proven clinical results. Tennis elbow patients find conservative treatment approaches, including physiotherapy, NSAIDs, and corticosteroid injections along with PRP therapy, orthotic bracing and ESWT to be effective for the majority of cases. Patients benefit from these treatment methods because they experience shorter recovery times, along with reduced side effects, and they avoid surgical complications. The growing patient preference for early intervention, combined with better physiotherapy facilities, leads most patients to choose non-invasive treatments as their initial approach. The development of wearable technological devices, which include smart braces and app-connected therapy tools makes non-surgical care more effective and attractive to patients. The widespread availability of outpatient medical facilities, together with insurance coverage support in various regions, strengthens the position of non-surgical treatment methods. The patient trend for minimally invasive treatments will make this segment maintain its dominant position in the future.

For instance, in May 2023, the FDA approved VibraCool, a new ice and vibration wearable, for the treatment of pain due to muscle tension and restriction in Tennis Elbow (tendinitis). Unlike opioids, electrical stimulation, VibraCool is non-invasive, drug-free, and portable.

North America Dominates the Lateral Epicondylitis Treatment Market

North America dominates the lateral epicondylitis treatment market because of its advanced healthcare system, combined with high condition awareness and advanced treatment accessibility. Tennis elbow affects many people in North America because the region has a large population of athletes, combined with workers who perform repetitive manual tasks. Patients living in North America have quick access to multiple non-surgical treatments, including physiotherapy together with corticosteroid injections and platelet-rich plasma (PRP), and shockwave therapy. The market receives additional strength from leading medical device manufacturers and sports medicine clinics as well as rehabilitation centers. Early diagnosis and treatment receive support from insurance coverage that is favorable and clinical guidelines that follow evidence-based practices. The region experiences faster adoption of orthotic device technology and regenerative medicine because of its strong healthcare innovation investments. North America holds the leading market position and innovation leadership for lateral epicondylitis treatment because of its aging yet physically active population and increasing emphasis on outpatient healthcare.

For instance, according to the Bureau of Labor Statistics (BLS), United States Department of Labor, reported private industry employers noted 2.6 million nonfatal injuries and illnesses in 2023, a decrease of 8.4% from 2022. These injuries led to an increased call for advanced treatment in the region and helped researchers develop innovative drugs in clinical trials on humans.

Impact of U.S. Tariffs on Lateral Epicondylitis Treatment Market

The supply chains for lateral epicondylitis treatment devices and biologic therapies have undergone subtle changes because of U.S. tariffs. The increased import expenses for shockwave machines, together with smart braces and diagnostic equipment from overseas suppliers, have led to higher operational costs for healthcare providers.

The response from major manufacturers involves supplier diversification and domestic production relocation, yet small clinics and specialized device producers find it difficult to handle the extra costs.

Tariff enforcement uncertainty has created delays in product development and rollout processes, which have reduced the pace of innovation adoption.

The uncertainty surrounding trade policies makes providers reluctant to replace their current equipment or purchase new orthotic devices.

The changes occurring at the industry level might lead to increased treatment expenses and reduced availability of advanced solutions, even though patients currently experience standard care quality.

Key Players Landscape and Outlook

The competitive landscape of the lateral epicondylitis treatment market is characterized by companies focusing on innovation, creating new product variants, and expanding globally. The market grows because of new non-surgical solutions, which include regenerative therapies together with wearable orthotic devices and shockwave therapy equipment. Companies increase their market presence by conducting research activities and developing clinical partnerships while entering expanding markets. Their competitive advantage stems from strategic efforts, which include launching new products and implementing digital therapy solutions along with providing better patient support services. The future outlook appears positive because emerging technological developments will maintain continuous market expansion along with growing consumer preference for noninvasive treatment methods.

In September 2024, the Food and Drug Administration approved Zynex Inc.'s new TensWave device, which matches Zynex's commitment to delivering complete pain management solutions. The recent FDA approval expands Zynex pain management product selection while continuing its goal of enhancing patient results using innovative medical devices.

1. Project Scope and Definitions

2. Research Methodology

3. Impact of the U.S. Tariffs

4. Executive Summary

5. Global Lateral Epicondylitis Treatment Market Outlook, 2018-2032F

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
5.2. Market Share Analysis & Forecast
- 5.2.1. By Treatment Type
  - 5.2.1.1. Non-surgical Treatment
    - 5.2.1.1.1. Medications
    - 5.2.1.1.2. Physical Therapy
    - 5.2.1.1.3. Orthotics and Braces
    - 5.2.1.1.4. Others
  - 5.2.1.2. Surgical Treatment
    - 5.2.1.2.1. Arthroscopic Surgery
    - 5.2.1.2.2. Open Surgery
    - 5.2.1.2.3. Others
- 5.2.2. By Age Group
  - 5.2.2.1. Pediatric
  - 5.2.2.2. Adult
  - 5.2.2.3. Geriatric
- 5.2.3. By End-user
  - 5.2.3.1. Hospitals
  - 5.2.3.2. Ambulatory Surgical Centers
  - 5.2.3.3. Orthopedic Clinics
  - 5.2.3.4. Homecare Settings
  - 5.2.3.5. Others
- 5.2.4. By Region
  - 5.2.4.1. North America
  - 5.2.4.2. Europe
  - 5.2.4.3. Asia-Pacific
  - 5.2.4.4. South America
  - 5.2.4.5. Middle East and Africa
- 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
5.3. Market Map Analysis, 2024
- 5.3.1. By Treatment Type
- 5.3.2. By Age Group
- 5.3.3. By End-user
- 5.3.4. By Region

6. North America Lateral Epicondylitis Treatment Market Outlook, 2018-2032F

6.1. Market Size Analysis & Forecast
- 6.1.1. By Value
6.2. Market Share Analysis & Forecast
- 6.2.1. By Treatment Type
  - 6.2.1.1. Non-surgical Treatment
    - 6.2.1.1.1. Medications
    - 6.2.1.1.2. Physical Therapy
    - 6.2.1.1.3. Orthotics and Braces
    - 6.2.1.1.4. Others
  - 6.2.1.2. Surgical Treatment
    - 6.2.1.2.1. Arthroscopic Surgery
    - 6.2.1.2.2. Open Surgery
    - 6.2.1.2.3. Others
- 6.2.2. By Age Group
  - 6.2.2.1. Pediatric
  - 6.2.2.2. Adult
  - 6.2.2.3. Geriatric
- 6.2.3. By End-user
  - 6.2.3.1. Hospitals
  - 6.2.3.2. Ambulatory Surgical Centers
  - 6.2.3.3. Orthopedic Clinics
  - 6.2.3.4. Homecare Settings
  - 6.2.3.5. Others
- 6.2.4. By Country Share
  - 6.2.4.1. United States
  - 6.2.4.2. Canada
  - 6.2.4.3. Mexico
6.3. Country Market Assessment
- 6.3.1. United States Lateral Epicondylitis Treatment Market Outlook, 2018-2032F*
  - 6.3.1.1. Market Size Analysis & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share Analysis & Forecast
    - 6.3.1.2.1. By Treatment Type
      - 6.3.1.2.1.1. Non-surgical Treatment
      - 6.3.1.2.1.1.1. Medications
      - 6.3.1.2.1.1.2. Physical Therapy
      - 6.3.1.2.1.1.3. Orthotics and Braces
      - 6.3.1.2.1.1.4. Others
      - 6.3.1.2.1.2. Surgical Treatment
      - 6.3.1.2.1.2.1. Arthroscopic Surgery
      - 6.3.1.2.1.2.2. Open Surgery
      - 6.3.1.2.1.2.3. Others
    - 6.3.1.2.2. By Age Group
      - 6.3.1.2.2.1. Pediatric
      - 6.3.1.2.2.2. Adult
      - 6.3.1.2.2.3. Geriatric
    - 6.3.1.2.3. By End-user
      - 6.3.1.2.3.1. Hospitals
      - 6.3.1.2.3.2. Ambulatory Surgical Centers
      - 6.3.1.2.3.3. Orthopedic Clinics
      - 6.3.1.2.3.4. Homecare Settings
      - 6.3.1.2.3.5. Others
- 6.3.2. Canada
- 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Lateral Epicondylitis Treatment Market Outlook, 2018-2032F

7.1. Germany
7.2. France
7.3. Italy
7.4. United Kingdom
7.5. Russia
7.6. Netherlands
7.7. Spain
7.8. Turkey
7.9. Poland

8. Asia-Pacific Lateral Epicondylitis Treatment Market Outlook, 2018-2032F

8.1. India
8.2. China
8.3. Japan
8.4. Australia
8.5. Vietnam
8.6. South Korea
8.7. Indonesia
8.8. Philippines

9. South America Lateral Epicondylitis Treatment Market Outlook, 2018-2032F

9.1. Brazil
9.2. Argentina

10. Middle East and Africa Lateral Epicondylitis Treatment Market Outlook, 2018-2032F

10.1. Saudi Arabia
10.2. UAE
10.3. South Africa

11. Porter's Five Forces Analysis

12. PESTLE Analysis

13. Pricing Analysis

14. Market Dynamics

14.1. Market Drivers
14.2. Market Challenges

15. Market Trends and Developments

16. Regulatory Framework and Innovation

16.1. Regulatory Approvals
16.2. Clinical Trials

17. Patent Landscape

18. Case Studies

19. Competitive Landscape

19.1. Competition Matrix of Top 5 Market Leaders
19.2. SWOT Analysis for Top 5 Players
19.3. Key Players Landscape for Top 10 Market Players
- 19.3.1. Pfizer, Inc.
  - 19.3.1.1. Company Details
  - 19.3.1.2. Key Management Personnel
  - 19.3.1.3. Products and Services
  - 19.3.1.4. Financials (As Reported)
  - 19.3.1.5. Key Market Focus and Geographical Presence
  - 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
- 19.3.2. GlaxoSmithKline plc
- 19.3.3. 3M Company
- 19.3.4. Merck & Co., Inc.
- 19.3.5. Bayer AG
- 19.3.6. Cipla Inc.
- 19.3.7. Novartis AG
- 19.3.8. Embla Medical hf.
- 19.3.9. Zimmer Biomet Holdings, Inc.
- 19.3.10. Enovis Corporation (DJO, LLC)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

外側上顆炎治療の世界市場、治療タイプ別、年齢層別、エンドユーザー別、地域別、機会、予測、2018年～2032年

Global Lateral Epicondylitis Treatment Market Assessment, By Treatment Type, By Age Group, By End-user, By Region, Opportunities and Forecast, 2018-2032F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 世界の外側上顆炎治療市場の展望、2018年～2032年

第6章 北米の外側上顆炎治療市場の展望、2018年～2032年

第7章 欧州の外側上顆炎治療市場の展望、2018年～2032年

第8章 アジア太平洋地域の外側上顆炎治療市場の展望、2018年～2032年

第9章 南米の外側上顆炎治療市場の展望、2018年～2032年

第10章 中東・アフリカの外側上顆炎治療市場の展望、2018年～2032年

第11章 ポーターのファイブフォース分析

第12章 PESTLE分析

第13章 価格分析

第14章 市場力学

第15章 市場動向と発展

第16章 規制枠組みとイノベーション

第17章 特許の情勢

第18章 ケーススタディ

第19章 競合情勢

第20章 戦略的提言

第21章 調査会社について・免責事項